Related Experiment Video

Updated: Jul 1, 2026

Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles
09:56

Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles

Published on: August 2, 2016

Decreasing systemic toxicity via transdermal delivery of anticancer drugs

Jia-You Fang1, Pei-Feng Liu, Chun-Ming Huang

  • 1Pharmaceutics Laboratory, Graduate Institute of Natural Products, Chang Gung University, Kweishan, Taoyuan, Taiwan.

Current Drug Metabolism
|September 11, 2008
PubMed

Insights

High-dose anticancer drugs cause toxicity. Transdermal delivery, using advanced skin technologies like erbium:YAG lasers, allows lower doses, reducing side effects for drugs such as 5-fluorouracil.

Area of Science:

  • Oncology
  • Dermatology
  • Pharmacology

Background:

  • High-dose anticancer chemotherapy can lead to severe hepatotoxicity and other systemic toxicities.
  • Transdermal drug delivery offers a potential solution by bypassing first-pass metabolism in the liver.
  • This approach may enable reduced drug dosage while maintaining therapeutic efficacy and minimizing adverse effects.

Purpose of the Study:

  • To review advanced transdermal drug delivery technologies for anticancer agents.
  • To discuss the application of these technologies for specific anticancer drugs: 5-fluorouracil (5-FU), methotrexate (MTX), and 5-aminolevulinic acid (5-ALA).
  • To highlight the potential of erbium:YAG (Er:YAG) laser-assisted transdermal delivery.

Main Methods:

  • Literature review of advanced transdermal delivery systems for anticancer drugs.
  • Focus on technologies enhancing skin permeation.
  • Specific examination of erbium:YAG laser applications in transdermal drug delivery.

Main Results:

  • Advanced transdermal technologies can improve skin delivery of anticancer drugs.
  • Transdermal delivery allows for lower effective doses, mitigating systemic toxicity.
  • Erbium:YAG laser technology shows promise for enhancing the transdermal permeation of drugs like 5-FU, MTX, and 5-ALA.

Conclusions:

  • Transdermal delivery represents a promising strategy to improve the safety profile of anticancer drugs.
  • Advanced technologies, particularly laser-assisted methods, offer novel ways to achieve effective transdermal anticancer chemotherapy.
  • Further research into these methods could lead to reduced patient toxicity and improved treatment outcomes.

More Related Videos

Using In Vitro Live-cell Imaging to Explore Chemotherapeutics Delivered by Lipid-based Nanoparticles10:26

Using In Vitro Live-cell Imaging to Explore Chemotherapeutics Delivered by Lipid-based Nanoparticles

Published on: November 1, 2017

Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice08:57

Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice

Published on: October 5, 2017

Related Concept Videos

Transdermal Drug Delivery Systems01:18

Transdermal Drug Delivery Systems

Transdermal drug delivery systems (TDDS) enable the controlled release of drugs across the skin into systemic circulation. They are particularly advantageous for drugs with short half-lives or narrow therapeutic indices, as they maintain consistent plasma concentrations and reduce the risk of subtherapeutic or toxic levels.TDDS are categorized into monolithic, reservoir, and mixed systems. Monolithic systems embed the drug in a polymer matrix, where diffusion governs release. Reservoir systems...
Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
Drug Distribution: Tissue Binding01:21

Drug Distribution: Tissue Binding

Upon entering the systemic circulation, drugs can distribute into the interstitial and intracellular fluid of various tissue cells. This distribution is facilitated by the binding of drugs to different cellular components within tissues, which may lead to drug accumulation in specific areas. Drugs bound to tissue components serve as reservoirs that release free drugs back into the system, prolonging the drug's overall action. However, this accumulation can also result in local toxicity.
For...
Drug Delivery Systems: Different Types01:27

Drug Delivery Systems: Different Types

Conventional oral drug products, termed immediate-release (IR) formulations, are engineered to promptly release their active pharmaceutical ingredient (API) upon ingestion, typically in tablets or capsules. This rapid release often results in swift drug absorption and consequent pharmacodynamic effects, although the timing and intensity can vary depending on the drug's properties. Prodrugs within these formulations require metabolic conversion to activate their pharmacodynamic effects,...
Drug Delivery: Overview01:16

Drug Delivery: Overview

The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the gastrointestinal...